CD155 and its receptors in cancer immune escape and immunotherapy
Ruijia Zhou(Central South University), Qiwen Wu(Central South University), Shiyin Chen(Central South University), Zhaoyang Zeng(Gansu University of Traditional Chinese Medicine), Yongzhen Mo(Central South University), Lingyun Liu(University of South China), Wei Xiong(Central South University), Fuyan Wang(W. L. Gore & Associates (Germany)), Xuyu Zu(Central South University), Yian Wang(Central South University)
Cited by 46
Related Papers
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|713
Effects of environmental pollutants on gut microbiota
|Environmental Pollution|2017|662
Regulatory mechanisms of PD-1/PD-L1 in cancers
|Molecular Cancer|2024|619
Single‐cell RNA sequencing in cancer research
|Journal of Experimental & Clinical Cancer Research|2021|377
Natural killer group 2D receptor and its ligands in cancer immune escape
|Molecular Cancer|2019|241